Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amplify Weight Loss Drug & Treatment ETF (THNR)

Amplify Weight Loss Drug & Treatment ETF (THNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Amplify ETFs
  • Assets Under Management 4,387,100
  • Shares Outstanding, K 180
  • 60-Month Beta N/A
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.59%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.36 +0.25%
on 11/13/24
26.61 -8.23%
on 10/15/24
-2.24 (-8.39%)
since 10/11/24
3-Month
24.36 +0.25%
on 11/13/24
28.19 -13.38%
on 08/30/24
-2.30 (-8.60%)
since 08/13/24

Most Recent Stories

More News
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 106.33 (-0.54%)
LLY : 798.41 (-1.65%)
HRTS : 32.87 (unch)
PPH : 89.12 (-0.40%)
THNR : 24.42 (-0.39%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 106.33 (-0.54%)
LLY : 798.41 (-1.65%)
HRTS : 32.87 (unch)
PPH : 89.12 (-0.40%)
THNR : 24.42 (-0.39%)
Tap the Weight-Loss Drug Market With These ETFs

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

RHHBY : 36.8100 (-0.57%)
NVO : 106.33 (-0.54%)
LLY : 798.41 (-1.65%)
HRTS : 32.87 (unch)
THNR : 24.42 (-0.39%)
OZEM : 26.80 (-0.73%)

Fund Summary

The Amplify Weight Loss Drug and Treatment ETF seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug and Treatment Index.

See More

Top 10 Holdings

Name % Holdings
Eli Lilly and Company 14.66%
Novo Nordisk A/S ADR 12.93%
Amgen Inc 5.42%
N/A 5.37%
N/A 5.18%
Pfizer Inc 5.04%
Thermo Fisher Scientific Inc 4.94%
Merck & Company 4.91%
N/A 4.67%
Astrazeneca Plc ADR 4.49%

See More

Key Turning Points

3rd Resistance Point 24.63
2nd Resistance Point 24.56
1st Resistance Point 24.49
Last Price 24.42
1st Support Level 24.36
2nd Support Level 24.29
3rd Support Level 24.22

See More

52-Week High 28.19
Fibonacci 61.8% 26.73
Fibonacci 50% 26.28
Fibonacci 38.2% 25.82
Last Price 24.42
52-Week Low 24.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar